Key result
Higher HbA1c is linked to increased risk of cardiovascular autonomic neuropathy in long-standing type 2 diabetes.
Why the study?
Cardiovascular autonomic neuropathy is a serious and underdiagnosed complication of long-standing type 2 diabetes with limited data from Indian populations on its relationship with somatic neuropathy.
Cross-Sectional (n=98)
No
Odds Ratio: 2.1
p-value: p=0.0055
In patients with long-standing type 2 diabetes, cardiovascular autonomic neuropathy is highly prevalent, and poorer glycemic control is the strongest independent predictor of its presence.
HbA1c may aid CAN risk assessment in long-standing T2D; leaves open whether tighter control reduces incidence.
BACKGROUND AND OBJECTIVES: Cardiovascular autonomic neuropathy (CAN) is a serious and underdiagnosed complication of long-standing type 2 diabetes mellitus, associated with increased cardiovascular morbidity and mortality. Data from Indian populations evaluating the relationship between somatic and autonomic neuropathy remain limited. METHODS: In this cross-sectional study, 98 patients with long-standing type 2 diabetes were evaluated at a tertiary-care center in Eastern India. Somatic neuropathy was assessed clinically and electrophysiologically, while autonomic function was evaluated using standard cardiovascular autonomic reflex tests and galvanic skin response (GSR). CAN was staged as possible, definite, or advanced. Clinical and metabolic correlates were analyzed, and multivariable logistic regression was used to identify factors independently associated with CAN. RESULTS: Distal symmetric polyneuropathy was present in 44.9% of patients, and any peripheral neuropathy was present in 59.2%. CAN was highly prevalent, with definite and advanced CAN observed in 28.6% and 46.9%, respectively. Abnormal GSR was noted in 42.9%, and overall diabetic autonomic involvement (defined as the presence of CAN and/or isolated sudomotor dysfunction) was present in 92.9%. Increasing CAN severity was associated with higher hemoglobin A1c (HbA1c) ( P = 0.0055), fasting blood glucose ( P = 0.0083), and age ( P = 0.0027), while duration showed a borderline association ( P = 0.0548). HbA1c was the only variable independently associated with CAN after multivariable adjustment (adjusted odds ratio ≈ 2.10 per 1% increase). The sustained handgrip test did not demonstrate a significant association with the presence of CAN (χ², P = 0.712), indicating limited discriminatory ability in this cohort. CONCLUSIONS: Autonomic neuropathy, particularly CAN, was highly prevalent in this cohort of patients with long-standing type 2 diabetes. Poorer glycemic control, reflected by higher HbA1c, showed the strongest independent association with CAN. Comprehensive autonomic assessment should be considered even in the absence of overt somatic neuropathy.
No takes yet. Share an insight, caveat, or question.
Samanta et al. (2026) conducted a cross-sectional in Long-standing type 2 diabetes mellitus (n=98). Higher hemoglobin A1c (HbA1c) was evaluated on Cardiovascular autonomic neuropathy (CAN) (OR 2.10, p=0.0055). Higher HbA1c was independently associated with cardiovascular autonomic neuropathy in patients with long-standing type 2 diabetes (adjusted OR approximately 2.10 per 1% increase).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: